FSD Pharma Inc. announced a non-brokered private placement of up to 24 Class A Shares at a price of CAD 1.90 per Class A Share for the gross proceeds of up to CAD 45.6, and expects that the entirety of the offering will be subscribed for by certain of the existing holders of Class A Shares on November 27, 2023. All Class A Shares issued pursuant to the offering will be subject to hold periods of four months and a day from the date of closing.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | -4.55% | -1.56% | -47.50% |
Apr. 25 | FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement | MT |
Apr. 08 | FSD Pharma Receives Nasdaq Non-Compliance Notice | MT |
1st Jan change | Capi. | |
---|---|---|
-47.50% | 19.34M | |
-2.51% | 103B | |
+1.67% | 95.28B | |
+1.43% | 22.15B | |
-15.53% | 21.02B | |
-8.45% | 18.15B | |
-41.01% | 16.73B | |
-13.62% | 16.05B | |
+4.00% | 13.68B | |
+34.54% | 12.17B |
- Stock Market
- Equities
- HUGE Stock
- News FSD Pharma Inc.
- FSD Pharma Inc. announced that it expects to receive CAD 0.000046 million in funding